|
End-of-day quote
Dhaka S.E.
2026-08-18
|
5-day change | 1st Jan Change | ||
| 776.90 BDT | -0.49% |
|
-2.49% | +9.73% |
| Market Cap | 1.82B 14.8M 12.78M 12.03M 10.93M 20.56M 1.42B 20.86M 141M 55.29M 709M 55.56M 54.36M 2.36B | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 18.93M 16.35M 15.38M 13.98M 26.29M 1.81B 26.68M 180M 70.7M 907M 71.06M 69.52M 3.02B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | -0.49% | ||
| 1 week | -2.49% | ||
| Current month | -4.44% | ||
| 1 month | -5.59% | ||
| 3 months | -0.33% | ||
| 6 months | +0.84% | ||
| Current year | +9.73% |
| 1 week | 765 |  | 808 |
| 1 month | 765 | | 847 |
| Current year | 689 | | 847 |
| 1 year | 681 | | 895 |
| 3 years | 610 | | 1,302.3 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 353 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.49% | -2.49% | -7.42% | +23.06% | 15.2M | |
| +1.09% | -2.76% | +16.21% | +66.19% | 46.96B | |
| +0.21% | -1.51% | +47.98% | +123.34% | 39.63B | |
| -0.11% | -2.30% | -7.72% | +15.85% | 12.07B | |
| +0.91% | -6.46% | +13.92% | +72.59% | 11.61B | |
| +0.58% | 0.00% | +30.65% | +147.62% | 9.11B | |
| -0.54% | -0.84% | +22.33% | +40.09% | 7.47B | |
| +0.47% | +1.57% | +42.92% | -11.71% | 7.18B | |
| -0.74% | -0.10% | +17.57% | +195.16% | 6.79B | |
| -0.97% | -2.30% | -30.37% | +24.93% | 5.75B | |
| Average | +0.03% | -0.76% | +14.61% | +69.71% | 14.66B | |
| Weighted average by Cap. | +0.35% | -2.15% | +23.40% | +82.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.79M 1.54M 1.45M 1.32M 2.48M 171M 2.52M 17.04M 6.68M 85.66M 6.71M 6.57M 285M | 231M 1.88M 1.62M 1.53M 1.39M 2.61M 180M 2.65M 17.91M 7.02M 90.06M 7.06M 6.9M 300M |
| Net income | 9.68M 78.93K 68.17K 64.14K 58.3K 110K 7.56M 111K 752K 295K 3.78M 296K 290K 12.6M | 5.31M 43.28K 37.38K 35.17K 31.96K 60.12K 4.15M 61K 413K 162K 2.07M 162K 159K 6.91M |
| Net Debt | 445M 3.62M 3.13M 2.95M 2.68M 5.04M 347M 5.11M 34.55M 13.54M 174M 13.61M 13.31M 579M | 506M 4.13M 3.56M 3.35M 3.05M 5.73M 395M 5.82M 39.34M 15.42M 198M 15.49M 15.16M 659M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-18 | BDT 776.90 | -0.49% | 2,834 |
| 26-08-17 | BDT 780.70 | -1.24% | 506 |
| 26-08-16 | BDT 790.50 | -1.53% | 163 |
| 26-08-13 | BDT 802.80 | +1.31% | 72 |
| 26-08-12 | BDT 792.40 | -0.54% | 388 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Select your edition
All financial news and data tailored to specific country editions
